Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension
Authors:
- Sakti MookherjeeSMSakti Mookherjee
- Anis ObeidAOAnis Obeid
- Robert WarnerRWRobert Warner
- Gunnar AndersonGAGunnar Anderson
- Robert EichRERobert Eich
- Harold SmulyanHSHarold Smulyan
- 1 December 1978
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 42 (6) , 987-992
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Hemodynamic correlates of saralasin-induced arterial pressure changes.Circulation, 1978
- Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.Circulation Research, 1977
- Identification of angiotensinogenic hypertension in man using 1-sar-8-ala-angiotensin II (Saralasin, P-113).Circulation Research, 1975
- Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” HypertensionNew England Journal of Medicine, 1975
- Radioimmunoassay and pharmacokinetics of saralasin in the rat and hypertensive patientsClinical Pharmacology & Therapeutics, 1975
- ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSUREThe Lancet, 1973
- Role of the Pressor Action of Angiotensin IIin Experimental HypertensionCirculation Research, 1971
- The Gradient in Pressure Across the Pulmonary Vascular Bed During DiastoleCirculation, 1966
- Outflow Resistance as an Independent Determinant of Cardiac PerformanceCirculation Research, 1961
- Some Different Types Of Essential HypertensionThe American Journal of the Medical Sciences, 1939